| Literature DB >> 23356424 |
Tadao Tokoro1, Kiyotaka Okuno, Jin-ichi Hida, Kazuki Ueda, Tahehito Yoshifuji, Koji Daito, Masako Takemoto, Fumiaki Sugiura.
Abstract
BACKGROUND: Intersphincteric resection (ISR) has been used to avoid permanent colostomy in very low rectal cancer patients. This study aimed to assess the surgical safety and oncologic and functional outcomes of ISR.Entities:
Mesh:
Year: 2013 PMID: 23356424 PMCID: PMC3570406 DOI: 10.1186/1477-7819-11-24
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Clinicopathological characteristics of patients who received intersphincteric resection (n = 30)
| Age, yearsa | 60.5 ± 9.9 |
| Histopathological gradeb | |
| G1 | 12 |
| G2 | 16 |
| Muc | 2 |
| Tumor location | |
| Anterior wall | 14 |
| Posterior wall | 12 |
| Left wall | 1 |
| Right wall | 2 |
| Circ | 1 |
| Tumor size, cma | 3.8 ± 1.5 |
| <4 cm | 18 |
| ≥4 cm | 12 |
| pT stage | |
| Tis | 1 (3.3%) |
| T1 | 8 (26.7%) |
| T2 | 10 (33.3%) |
| T3 | 11 (36.7%) |
| TNM stage | |
| 0 | 1 |
| I | 16 |
| IIA | 5 |
| IIIA | 2 |
| IIIB | 5 |
| IVA | 1 |
aValues denote mean ± SD.
bDifferentiation of adenocarcinoma: G1 = well differentiated; G2 = moderately differentiated; Muc = mucinous carcinoma. Circ = circumferential tumor.
Differences in clinicopathological characteristics between intersphincteric resection (ISR) procedures
| Sex | | | |
| Male | 6 | 2 | 6 |
| Female | 6 | 2 | 8 |
| Type of reconstruction | | | |
| Colonic J-pouch | 9 | 4 | 13 |
| Straight | 3 | 0 | 1 |
| Combined with partial ESR | 0 | 2 | 2 |
| Distance between the distal edge of the tumor and | 16.0 ± 4.6 | 5.0 ± 4.1 | 3.5 ± 5.1 |
| Distal resection margin, mma | 8.7 ± 6.0 | 9.5 ± 10.5 | 7.2 ± 5.4 |
| CRM, mma | 3.2 ± 2.7 | 4.8 ± 3.1 | 3.6 ± 2.1 |
| No. of stoma closuresb | 9 (81.8) | 2 (50) | 8 (57.1) |
aValues indicate mean ± SD.
bData in parentheses represent percentage values in each group.
CRM = circumferential resection margin; ESR = external sphincteric resection; ISR = intersphincteric resection.
Characteristics of six patients with local recurrence after intersphincteric resection (ISR)
| 1 | IIA | T3 | G2 | tISR + pESR | 7 | 2 | Pelvic wall | NS | CRT | 45 months, O |
| 2 | IIIB | T3 | G2 | sISR + pESR | 25 | 2 | Pelvic wall | NS | CRT | 70 months, S |
| 3 | IIIB | T3 | G2 | pISR | 12 | 5 | Pelvic wall | Bone, lung | Cx | 31 months, P |
| 4 | IIA | T3 | G2 | pISR | 10 | 0.5 | Lateral node | Adrenal gland | Cx | 36 months, P |
| 5 | I | T2 | G1 | pISR | 3 | 6 | Anastomosis | NS | APR | 22 months, S |
| 6 | IIB | T3 | G1 | pISR | 3 | 0.5 | Lateral node | NS | CRT | 17 months, S |
Distal resection margins and circumferential resection margins were measured on the histological slides.
APR = abdominoperineal resection; CRT = chemoradiotherapy; Cx = chemotherapy; ESR = external intersphincteric resection; ISR = intersphincteric resection; NS = not stated; O = other origin of death; P = primary death; S = survived.
Figure 1Rates of local recurrence among 30 patients undergoing intersphincteric resection according to the pathologic depth of the tumors (T stage).
Wexner scores at 3, 6, and 12 months in patients who underwent intersphincteric resection (ISR) followed by stoma closure
| Surgical procedure | | | |
| Partial ISR (n = 9) | 13.3 ± 3.1 | 12.1 ± 3.0* | 11.8 ± 2.6 |
| Subtotal or total ISR (n = 10) | 13.0 ± 3.8 | 11.5 ± 4.9 | 9.1 ± 5.6 |
| Anastomotic stricture | | | |
| Yes (n = 5) | 15.4 ± 2.9 | 13.4 ± 4.5 | 13.6 ± 3.9 |
| No (n =14) | 12.4 ± 3.3 | 11.2 ± 3.9* | 9.0 ± 4.5* |
Data are shown as mean ± SD. Data at 6 and 12 months were statistically compared with those at 3 months using the Wilcoxon signed-rank test.
*P <0.05.
Anal dysfunction after stoma closure in patients with anastomotic stricture and those with no anastomotic stricture
| Stool frequency, times/day | 6.4 ± 3.6 | 11.4 ± 3.0** | 6.8 ± 2.8 | 7.0 ± 2.1 | 5.1 ± 2.9 | 9.0 ± 5.3** |
| Urgency | 12/14 | 4/5 | 8/13 | 2/5 | 3/12* | 4/5** |
| Fragmentation | 10/14 | 5/5 | 7/13 | 4/5 | 4/12 | 5/5** |
| Dyschesia | 2/14 | 3/5 | 2/13 | 0/5 | 2/12 | 0/5 |
| Medication use | 4/14 | 4/5 | 3/13 | 4/5** | 2/12 | 3/5 |
| Nocturnal defecation | 9/14 | 5/5 | 5/13* | 5/5 | 5/12* | 4/5 |
Data associated with each anal dysfunction at 6 and 12 months were statistically compared with those at 3 months for each condition of anastomotic sites using Wilcoxon signed-rank test. *P <0.05.
Data associated with each anal dysfunction of the stricture group were statistically compared with those of the non-stricture group at 3, 6, and 12 months using the Mann–Whitney U test. **P <0.05.